For instance, SIRT2 can encourage the progression of liver cancer through the activation of Akt and subsequent inhibition of epithelial-mesenchymal transition GSK-3, which leads to the raising of the β-catenin protein. The gene discussed is SIRT2; the disease is liver cancer.